Table 1 Abdominal aortic aneurysms (AAA) and chronic obstructive pulmonary disease (COPD): Prevalence and incidence studies.
Study (published year) | Study type | Male (%) | Age | Region | AAA (case/total) | No AAA (case/control) | Reported OR (95% CI) | P | Comments |
|---|---|---|---|---|---|---|---|---|---|
Lederle et al. (1988) | PBS | 100 | ≥60 | US | 1/18 | 7/183 | NA | NA | |
Smith et al. (1993) | PBS | 100 | ≥65 | UK | 28/219 | 205/2378 | NA | <0.05 | |
Simoni et al. (1995) | PBS | 46 | ≥65 | Italy | 22/70 | 126/1504 | NA | <0.001 | |
Lederle et al. (1997) (1)¶ | PBS | 97 | ≥50 | US | NA | NA | 1.04 (0.92–1.16)* | NA | AAA (3.0–3.9cm) |
Lederle et al. (1997) (2)¶ | PBS | 97 | ≥50 | US | NA | NA | 1.28 (1.09–1.50)* | NA | AAA (≥4.0cm) |
Lindholt et al. (1998) | PBS | 100 | ≥65 | Denmark | 16/139 | 264/4265 | 2.05 (1.14–3.62) | 0.01 | |
Lederle et al. (2000) (1)§ | PBS | 97 | ≥50 | US | NA | NA | 1.11 (0.95–1.30)* | NA | AAA (3.0–3.9cm) |
Lederle et al. (2000) (2)§ | PBS | 97 | ≥50 | US | NA | NA | 1.08 (0.86–1.36)* | NA | AAA (≥4.0cm) |
Shteinberg et al. (2000) | CCS | 88 | ≥43 | Israel | 28/82 | 19/73 | NA | NS | AAA vs. PAOD |
Petersen et al. (2002) | CCS | 70 | ≥50 | Sweden | 2/10 | 3/30 | NA | NA | AAA vs (AOD + SCS + NAM) |
Barba et al. (2005) | CCS | 93.7 | NA | Spain | 40/151 | 184/1015 | NA | 0.015 | AAA vs. PAOD |
Fowkes et al. (2006) | CCS | 72 | 74m | UK | 87/89 | 94/98 | NA | NA | AAA vs. No |
Yaghoubian et al. (2006) | CCS | 91 | 74m | US | 14/100 | 1/100 | 16.1 (2.08–125.1) | 0.0005 | AAA vs. No |
Iribarren et al. (2007) | PS | 45 | >18 | US | NA | NA | 1.25 (0.94–1.65)* | NA | AAA/No AAA: 605/104208 |
Koksal et al. (2007) | CCS | NA | ≥47 | Turkey | 7/40 | 9/40 | NA | NA | AAA vs. AOD |
Ito et al. (2008) | CCS | 78.7 | 73m | Japan | 63/211 | 20/132 | 2.38 (1.28–4.26); 2.05 (1.11–3.89)* | 0.002; 0.025* | AAA vs. TAA |
Lederle et al. (2008) | PS | 0 | ≥50 | US | 22/184 | 5657/161624 | 1.44 (0.88–2.37)* | NA | |
Svensjo et al. (2011) | PBS | 100 | 65 | Sweden | 21/233 | 920/14378 | 1.2 (0.8–1.9)* | 0.44* | |
Duncan et al. (2012) | PS | 100 | ≥65 | UK | 73/414 | 623/7063 | 3.13 (2.28–4.30);1.98 (1.37–2.86)* | NA | |
Pitoulias et al. (2012) | CCS | 88.2 | ≥45 | Greece | 35/110 | 10/60 | 0.43 (0.20–0.94);0.65 (0.27–1.58)* | 0.035 0.34* | AAA vs. AOD |
Saracini et al. (2012) | CCS | 87.7 | ≥40 | Italy | 311/423 | 66/423 | NA | NA | AAA vs. No |
Svensjo et al. (2013) | PBS | 0 | 70 | Sweden | 3/19 | 447/5120 | 1.96 (0.57–6.75) | 0.277 | |
Chun et al. (2014) | PBS | 99.6 | ≥50 | US | 122/469 | 647/5673 | 1.75 (1.41–2.18) | <0.001 |
